These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18222579)

  • 1. Promoting research participation: why not advertise altruism?
    Williams B; Entwistle V; Haddow G; Wells M
    Soc Sci Med; 2008 Apr; 66(7):1451-6. PubMed ID: 18222579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive evidence-based approach is needed for promoting participation in health research: a commentary on Williams.
    Fry CL
    Soc Sci Med; 2008 Apr; 66(7):1457-60; discussion 1461-2. PubMed ID: 18222584
    [No Abstract]   [Full Text] [Related]  

  • 3. Involving older people in research: methodological issues.
    Ross F; Donovan S; Brearley S; Victor C; Cottee M; Crowther P; Clark E
    Health Soc Care Community; 2005 May; 13(3):268-75. PubMed ID: 15819748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participating in research: exploring participation and engagement in a study of self-management for people with chronic obstructive pulmonary disease.
    Willis KF; Robinson A; Wood-Baker R; Turner P; Walters EH
    Qual Health Res; 2011 Sep; 21(9):1273-82. PubMed ID: 21474655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "It's no skin off my nose": why people take part in qualitative research.
    Peel E; Parry O; Douglas M; Lawton J
    Qual Health Res; 2006 Dec; 16(10):1335-49. PubMed ID: 17079797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noncompliance in clinical trials: I. Subjects.
    Novick A
    AIDS Public Policy J; 1990; 5(2):94-6. PubMed ID: 11659266
    [No Abstract]   [Full Text] [Related]  

  • 8. What motivates women to take part in clinical and basic science endometriosis research?
    Agarwal SK; Estrada S; Foster WG; Wall LL; Brown D; Revis ES; Rodriguez S
    Bioethics; 2007 Jun; 21(5):263-9. PubMed ID: 17845471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empirical data and the acceptability of research risk: a commentary on the charitable participation standard.
    Reynolds WW; Nelson RM
    Arch Pediatr Adolesc Med; 2008 Jan; 162(1):88-90. PubMed ID: 18180419
    [No Abstract]   [Full Text] [Related]  

  • 10. Appealing to altruism is not enough: motivators for participating in health services research.
    Hunter J; Corcoran K; Leeder S; Phelps K
    J Empir Res Hum Res Ethics; 2012 Jul; 7(3):84-90. PubMed ID: 22850146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An investigation of patients' motivations for their participation in genetics-related research.
    Hallowell N; Cooke S; Crawford G; Lucassen A; Parker M; Snowdon C
    J Med Ethics; 2010 Jan; 36(1):37-45. PubMed ID: 20026692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Undue fear of inducements in research in developing countries.
    Arnason G; Van Niekerk A
    Camb Q Healthc Ethics; 2009 Apr; 18(2):122-9. PubMed ID: 19250565
    [No Abstract]   [Full Text] [Related]  

  • 14. Reasons for participating in randomised controlled trials: conditional altruism and considerations for self.
    McCann SK; Campbell MK; Entwistle VA
    Trials; 2010 Mar; 11():31. PubMed ID: 20307273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accessing health services through the back door: a qualitative interview study investigating reasons why people participate in health research in Canada.
    Townsend A; Cox SM
    BMC Med Ethics; 2013 Oct; 14():40. PubMed ID: 24119203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the acceptability and feasibility of conducting a large longitudinal population-based study in Canada.
    Kirkland SA; Raina PS; Wolfson C; Strople G; Kits O; Dukeshire S; Angus CL; Szala-Meneok K; Uniat J; Keshavarz H; Furlini L; Pelletier A
    Can J Aging; 2009 Sep; 28(3):231-42. PubMed ID: 19860978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In the mood for science: a discussion of emotion management in a pharmacogenomics research encounter in Denmark.
    Svendsen MN; Koch L
    Soc Sci Med; 2011 Mar; 72(5):781-8. PubMed ID: 21316831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Gift without a price tag': altruism in anonymous semen donation.
    Yee S
    Hum Reprod; 2009 Jan; 24(1):3-13. PubMed ID: 18819964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive and negative aspects of participation in illicit drug research: implications for recruitment and ethical conduct.
    Barratt MJ; Norman JS; Fry CL
    Int J Drug Policy; 2007 May; 18(3):235-8. PubMed ID: 17689370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential motivations for and perceived risks in research participation: ethics in health research.
    Sikweyiya Y; Jewkes R
    Qual Health Res; 2013 Jul; 23(7):999-1009. PubMed ID: 23660499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.